ADMA Biologics Inc
NASDAQ:ADMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
C
|
Carpenter Technology Corp
SWB:XTY
|
US |
|
Wheaton Precious Metals Corp
TSX:WPM
|
CA |
|
P
|
ProKidney Corp
NASDAQ:PROK
|
US |
|
O
|
Oracle Corp
F:ORC
|
US |
|
Z
|
Zalekta PCL
SET:ZAA
|
TH |
|
Beam Global
F:16NA
|
US |
|
H
|
He Group Bhd
KLSE:HEGROUP
|
MY |
|
L
|
Lamar Advertising Co
DUS:6LA
|
US |
|
B
|
BenoHoldings Inc
KOSDAQ:206400
|
KR |
|
M
|
Mitie Group PLC
OTC:MITFF
|
UK |
|
B
|
Bank of Nova Scotia
SWB:BKN
|
CA |
|
Quang Viet Enterprise Co Ltd
TWSE:4438
|
TW |
|
T
|
Tabcorp Holdings Ltd
XMUN:THL
|
AU |
|
Fu Yu Corporation Ltd
SGX:F13
|
SG |
|
Askoll Eva SpA
F:736
|
IT |
|
T
|
Techna-X Bhd
KLSE:TECHNAX
|
MY |
|
PepsiCo Inc
NASDAQ:PEP
|
US |
|
M
|
MS&AD Insurance Group Holdings Inc
XMUN:59M
|
JP |
|
Transcat Inc
F:TR8
|
US |
|
Mountain Commerce Bancorp Inc
OTC:MCBI
|
US |
|
D
|
Didim E&F Inc
KOSDAQ:217620
|
KR |
|
Midland States Bancorp Inc
NASDAQ:MSBI
|
US |
|
A
|
Aco Group Bhd
KLSE:ACO
|
MY |
Bankruptcy Probability
ADMA Biologics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ADMA Biologics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
2.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ADMA Biologics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ADMA Biologics Inc has total debt of 192.8m USD. This includes both short-term (0 USD) and long-term (192.8m USD) debt.
You can find a full breakdown on its Balance Sheet.
